Christopher Powala
2017
In 2017, Christopher Powala earned a total compensation of $536.2K as Chief Regulatory and Development Officer at Aclaris Therapeutics, a 75% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,803 |
|---|---|
| Salary | $385,000 |
| Other | $11,436 |
| Total | $536,239 |
Powala received $385K in salary, accounting for 72% of the total pay in 2017.
Powala also received $139.8K in non-equity incentive plan and $11.4K in other compensation.
Rankings
In 2017, Christopher Powala's compensation ranked 11,605th out of 14,666 executives tracked by ExecPay. In other words, Powala earned more than 20.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,605 out of 14,666 | 21st |
Division Manufacturing | 4,554 out of 5,772 | 21st |
Major group Chemicals And Allied Products | 1,665 out of 2,075 | 20th |
Industry group Drugs | 1,378 out of 1,731 | 20th |
Industry Pharmaceutical Preparations | 1,075 out of 1,333 | 19th |
Source: SEC filing on April 26, 2018.
Powala's colleagues
We found two more compensation records of executives who worked with Christopher Powala at Aclaris Therapeutics in 2017.